| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
81,714 |
73,668 |
$7.68M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,788 |
31,798 |
$2.74M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,087 |
4,409 |
$809K |
| 36415 |
Collection of venous blood by venipuncture |
41,296 |
35,192 |
$780K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,266 |
8,591 |
$741K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,588 |
4,853 |
$647K |
| 80053 |
Comprehensive metabolic panel |
31,568 |
26,281 |
$431K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,952 |
2,570 |
$388K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,769 |
3,313 |
$355K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,497 |
4,580 |
$319K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,636 |
2,465 |
$265K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,167 |
3,971 |
$202K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,759 |
19,375 |
$182K |
| 87070 |
|
9,469 |
8,632 |
$180K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,709 |
7,701 |
$125K |
| 71045 |
Radiologic examination, chest; single view |
19,528 |
17,056 |
$122K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
829 |
713 |
$109K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,334 |
9,049 |
$90K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,251 |
1,055 |
$81K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,191 |
844 |
$54K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,645 |
2,039 |
$50K |
| 81001 |
|
11,531 |
9,626 |
$47K |
| 71046 |
Radiologic examination, chest; 2 views |
2,776 |
2,393 |
$43K |
| 74018 |
|
1,821 |
1,671 |
$35K |
| 81003 |
|
15,180 |
13,694 |
$34K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12,664 |
10,098 |
$30K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,683 |
1,510 |
$29K |
| 73610 |
|
1,355 |
1,179 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,239 |
2,655 |
$26K |
| 73130 |
|
1,292 |
1,161 |
$26K |
| 73562 |
|
1,438 |
1,242 |
$23K |
| 81025 |
|
9,582 |
8,577 |
$22K |
| 87802 |
|
5,619 |
4,850 |
$22K |
| 73630 |
|
1,371 |
1,241 |
$20K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
589 |
546 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,406 |
10,342 |
$19K |
| 72131 |
|
607 |
511 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,709 |
2,378 |
$17K |
| 12011 |
|
189 |
179 |
$17K |
| 12001 |
|
195 |
189 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
505 |
407 |
$15K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,151 |
1,019 |
$15K |
| 73030 |
|
1,047 |
878 |
$13K |
| 76801 |
|
1,481 |
1,196 |
$13K |
| G0378 |
Hospital observation service, per hour |
3,183 |
1,653 |
$13K |
| 73110 |
|
829 |
724 |
$13K |
| 76830 |
Ultrasound, transvaginal |
885 |
774 |
$12K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,512 |
9,800 |
$12K |
| 85027 |
|
37,157 |
30,149 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,980 |
8,308 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,930 |
12,413 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
665 |
584 |
$10K |
| 72100 |
|
857 |
751 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,859 |
2,643 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
29 |
24 |
$8K |
| 84484 |
|
7,470 |
5,292 |
$7K |
| 87040 |
|
955 |
710 |
$7K |
| 93971 |
|
437 |
399 |
$6K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
5,246 |
4,835 |
$5K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
120 |
79 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
531 |
455 |
$5K |
| 87807 |
|
1,411 |
1,275 |
$5K |
| 73080 |
|
256 |
239 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,330 |
7,762 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,656 |
1,350 |
$4K |
| A9270 |
Non-covered item or service |
3,736 |
1,072 |
$4K |
| 83880 |
|
3,781 |
3,135 |
$4K |
| 84703 |
|
6,869 |
5,813 |
$3K |
| 84702 |
|
2,669 |
2,090 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
90 |
79 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,182 |
943 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
396 |
336 |
$3K |
| 10060 |
|
54 |
52 |
$3K |
| 87430 |
|
1,846 |
1,797 |
$3K |
| 83690 |
|
10,288 |
8,785 |
$3K |
| 87210 |
|
830 |
742 |
$2K |
| 86900 |
|
1,520 |
1,301 |
$2K |
| 93017 |
|
162 |
107 |
$2K |
| 73590 |
|
125 |
103 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,742 |
5,174 |
$2K |
| 83735 |
|
7,173 |
5,649 |
$2K |
| 85610 |
|
5,336 |
4,274 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,409 |
1,234 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,197 |
3,318 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,412 |
1,237 |
$1K |
| 85379 |
|
2,354 |
1,996 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
1,011 |
562 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,630 |
2,949 |
$1K |
| 80061 |
Lipid panel |
890 |
693 |
$1K |
| 85730 |
|
3,052 |
2,445 |
$839.83 |
| 74021 |
|
48 |
42 |
$834.88 |
| 80047 |
|
609 |
533 |
$759.41 |
| 72040 |
|
113 |
103 |
$751.54 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,791 |
1,472 |
$745.80 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,593 |
4,325 |
$730.56 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,545 |
2,142 |
$690.19 |
| 90715 |
|
475 |
414 |
$633.94 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,553 |
1,383 |
$475.25 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
167 |
144 |
$463.66 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,907 |
1,760 |
$440.58 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,231 |
1,042 |
$348.04 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,867 |
1,628 |
$315.13 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,821 |
1,550 |
$260.98 |
| 84145 |
|
72 |
55 |
$161.82 |
| 82550 |
|
298 |
235 |
$154.68 |
| 85651 |
|
205 |
191 |
$114.78 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,189 |
1,865 |
$83.09 |
| J2060 |
Injection, lorazepam, 2 mg |
818 |
630 |
$75.88 |
| 70486 |
|
14 |
14 |
$70.88 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
229 |
163 |
$67.30 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
105 |
66 |
$52.64 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
778 |
687 |
$32.59 |
| 86850 |
|
453 |
395 |
$16.66 |
| 96376 |
|
466 |
413 |
$14.51 |
| 86140 |
|
189 |
172 |
$13.05 |
| 87186 |
|
854 |
763 |
$10.67 |
| 83605 |
|
826 |
655 |
$8.00 |
| 80076 |
|
419 |
375 |
$6.74 |
| 86901 |
|
1,489 |
1,278 |
$5.44 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
439 |
321 |
$4.91 |
| 87147 |
|
190 |
152 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
80 |
66 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
446 |
253 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
156 |
131 |
$0.00 |
| 80320 |
|
166 |
133 |
$0.00 |
| 83615 |
|
32 |
26 |
$0.00 |
| 73090 |
|
30 |
28 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
86 |
64 |
$0.00 |
| 80329 |
|
36 |
26 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
28 |
25 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
14 |
13 |
$0.00 |
| 82553 |
|
44 |
24 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
34 |
27 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
39 |
26 |
$0.00 |
| 82077 |
|
15 |
13 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$0.00 |
| 84100 |
|
86 |
80 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
44 |
39 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
45 |
40 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
75 |
71 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
208 |
179 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
33 |
32 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
55 |
46 |
$0.00 |
| 82800 |
|
17 |
17 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
85 |
75 |
$0.00 |
| J0595 |
Injection, butorphanol tartrate, 1 mg |
61 |
28 |
$0.00 |
| 82009 |
|
14 |
13 |
$0.00 |